
DH does not currently pay a dividend.
Sell-side consensus EPS, revenue estimates, YoY growth, forward P/E, and per-year analyst coverage — for any covered stock.
Click below to see what's inside, then upgrade to unlock for this and 80,000+ other tickers.
A year-by-year projected price path from the sell-side EPS consensus, with an editable target P/E and the implied annual return from today's price.
Click below to see what's inside, then upgrade to unlock for DH and 80,000+ other tickers.
See price against where its own fundamentals say it should trade — the shaded gap is the discount or premium, across five valuation lenses.
Click below to see what's inside, then upgrade to unlock for DH and 80,000+ other tickers.
See exactly how DH's revenue becomes profit — a Sankey that traces revenue (and its reported segments) through gross profit, operating expenses, and net profit, with the year-over-year change on every line.
The same diagram the Chart Builder draws, right on the Summary tab. Upgrade to unlock it for DH and 80,000+ other tickers.
Definitive Healthcare Corp. (DH), operating through its various subsidiaries, offers specialized commercial intelligence solutions for the U.S. healthcare industry. The company's services furnish essential data on healthcare providers and their activities, enabling clients to navigate critical business processes, from the early stages of product development to strategic market entry planning and effective sales and marketing execution. Its sophisticated platform incorporates sixteen distinct intelligence modules. These modules are designed to support key functional domains such as sales…

Definitive Healthcare Corp. (NASDAQ: DH - Get Free Report) has received a consensus rating of "Reduce" from the nine analysts that are covering the firm, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell recommendation, five have issued a hold recommendation and one has assigned a strong buy recommendation to the company.

Definitive Healthcare Corp. (DH) Q2 2026 Earnings Call Transcript

Definitive Healthcare Corp. (DH) came out with quarterly earnings of $0.05 per share, beating the Zacks Consensus Estimate of $0.04 per share. This compares to earnings of $0.07 per share a year ago.

Definitive Healthcare NASDAQ: DH reported second-quarter fiscal 2026 revenue and profitability that met or exceeded its guidance ranges, while management pointed to improving retention trends and continued investments in artificial intelligence products as key components of its plan to return to growth.

Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions Unifying claims, provider, consumer, and expert data enables organizations to uncover growth opportunities and make faster, better-informed decisions